valine and valganciclovir

valine has been researched along with valganciclovir in 24 studies

Research

Studies (24)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's9 (37.50)29.6817
2010's15 (62.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zaia, JA1
Emery, VC; Leśnikowski, ZJ; Olejniczak, A; Paradowska, E; Przepiórkiewicz, M1
Guex-Crosier, Y; Meylan, PR1
Brandl, M; Stefanidis, D1
Falagas, ME; Vardakas, KZ1
Hes, O; Jindra, P; Klaboch, J; Reischig, T; Svecová, M; Treska, V1
Amidon, GL; Lai, L; Lee, KD; Xu, Z; Zhou, J1
Smolej, L1
Bowlin, TL; Drach, JC; Prichard, MN; Wu, Z; Yanachkov, I; Yanachkova, M; Zemlicka, J1
Bouda, M; Hes, O; Jindra, P; Nemcová, J; Reischig, T; Treska, V; Vanecek, T1
Akl, A; Blancho, G; Cantarovich, D; Dantal, J; Giral, M; Leone, F; Soulillou, JP1
Aydinli, B; Bilen, Y; Cetinkaya, R; Keles, M; Polat, KY; Turkmen, M; Uyanik, A; Yildirim, R1
Chiang, CC; Lin, TH; Tien, PT; Tsai, YY1
Khuroo, A; Mishra, S; Monif, T; Saxena, S; Singh, O1
Razonable, RR1
Reischig, T1
Bouda, M; Jindra, P; Lysak, D; Matejovic, M; Prucha, M; Reischig, T; Sedlackova, L1
Brennan, DC; Santos, RD1
Bouda, M; Hes, O; Hribova, P; Jindra, P; Reischig, T; Treska, V; Viklicky, O1
Alexopoulos, SP; Lindberg, L; Matsuoka, L; Subramanyan, RK1
Cunningham, ET; Fu, A; Johnson, RN; Jumper, JM; Lujan, BJ; McDonald, HR; Wong, RW1
Beersma, MF; Bouts, AH; Cornelissen, EA; Cransberg, K; Jongsma, H1
Bouda, M; Hes, O; Jindra, P; Kacer, M; Lysak, D; Reischig, T1
Bouda, M; Kacer, M; Kielberger, L; Reischig, T1

Reviews

4 review(s) available for valine and valganciclovir

ArticleYear
[Drugs against human cytomegalovirus].
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2002, Volume: 13, Issue:75

    Topics: Acyclovir; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drugs, Investigational; Female; Foscarnet; Ganciclovir; Global Health; Humans; Infectious Disease Transmission, Vertical; Naphthalenesulfonates; Organophosphonates; Organophosphorus Compounds; Pregnancy; Pregnancy Complications, Infectious; Thionucleotides; Valacyclovir; Valganciclovir; Valine

2002
Antiviral drugs for viruses other than human immunodeficiency virus.
    Mayo Clinic proceedings, 2011, Volume: 86, Issue:10

    Topics: Acyclovir; Adenine; Amantadine; Antiviral Agents; Comorbidity; Drug Therapy, Combination; Foscarnet; Ganciclovir; Guanine; Hepatitis; Hepatitis B, Chronic; Hepatitis C; Herpesviridae Infections; HIV Infections; Humans; Influenza, Human; Interferons; Lamivudine; Nucleosides; Oligopeptides; Organophosphonates; Oseltamivir; Proline; Protease Inhibitors; Pyrimidinones; Ribavirin; Telbivudine; Thymidine; Valacyclovir; Valganciclovir; Valine; Virus Replication; Zanamivir

2011
Advances in cytomegalovirus-preventive strategies in solid organ transplantation: defending pre-emptive therapy.
    Expert review of anti-infective therapy, 2012, Volume: 10, Issue:1

    Topics: Acyclovir; Antiviral Agents; Clinical Protocols; Cytomegalovirus Infections; Ganciclovir; Humans; Immunosuppressive Agents; Opportunistic Infections; Organ Transplantation; Randomized Controlled Trials as Topic; Valacyclovir; Valganciclovir; Valine

2012
Emerging concepts in the management of acute retinal necrosis.
    The British journal of ophthalmology, 2013, Volume: 97, Issue:5

    Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Cytomegalovirus Retinitis; Eye Infections, Viral; Famciclovir; Fluorescein Angiography; Ganciclovir; Herpes Simplex; Humans; Laser Coagulation; Retinal Necrosis Syndrome, Acute; Valacyclovir; Valganciclovir; Valine

2013

Trials

5 trial(s) available for valine and valganciclovir

ArticleYear
Valacyclovir prophylaxis versus preemptive valganciclovir therapy to prevent cytomegalovirus disease after renal transplantation.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2008, Volume: 8, Issue:1

    Topics: Acyclovir; Adult; Aged; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Czech Republic; Ganciclovir; Humans; Incidence; Kidney Transplantation; Middle Aged; Prospective Studies; Valacyclovir; Valganciclovir; Valine

2008
Intragraft cytomegalovirus infection: a randomized trial of valacyclovir prophylaxis versus pre-emptive therapy in renal transplant recipients.
    Antiviral therapy, 2010, Volume: 15, Issue:1

    Topics: Acyclovir; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Double-Blind Method; Ganciclovir; Graft Rejection; Humans; Kidney Transplantation; Postoperative Complications; Premedication; Risk Factors; Transplantation, Homologous; Treatment Outcome; Valacyclovir; Valganciclovir; Valine; Viremia

2010
Determination of valganciclovir and ganciclovir in human plasma by liquid chromatography tandem mass spectrometric detection.
    Clinical biochemistry, 2011, Volume: 44, Issue:10-11

    Topics: Acyclovir; Calibration; Chromatography, Liquid; Drug Stability; Ganciclovir; Humans; Reproducibility of Results; Tandem Mass Spectrometry; Time Factors; Valacyclovir; Valganciclovir; Valine

2011
Long-term outcomes of pre-emptive valganciclovir compared with valacyclovir prophylaxis for prevention of cytomegalovirus in renal transplantation.
    Journal of the American Society of Nephrology : JASN, 2012, Volume: 23, Issue:9

    Topics: Acyclovir; Adult; Antiviral Agents; Atrophy; Biopsy; Cytomegalovirus; Cytomegalovirus Infections; Female; Fibrosis; Follow-Up Studies; Ganciclovir; Graft Survival; Humans; Kaplan-Meier Estimate; Kidney; Kidney Transplantation; Longitudinal Studies; Male; Middle Aged; Treatment Outcome; Valacyclovir; Valganciclovir; Valine

2012
Randomized trial of valganciclovir versus valacyclovir prophylaxis for prevention of cytomegalovirus in renal transplantation.
    Clinical journal of the American Society of Nephrology : CJASN, 2015, Feb-06, Volume: 10, Issue:2

    Topics: Acute Disease; Acyclovir; Adult; Antiviral Agents; Biomarkers; Biopsy; Cytomegalovirus; Cytomegalovirus Infections; Czech Republic; DNA, Viral; Drug Administration Schedule; Female; Ganciclovir; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Intention to Treat Analysis; Kidney Transplantation; Male; Middle Aged; Time Factors; Treatment Outcome; Valacyclovir; Valganciclovir; Valine; Viral Load

2015

Other Studies

15 other study(ies) available for valine and valganciclovir

ArticleYear
Prevention of cytomegalovirus disease in hematopoietic stem cell transplantation.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Oct-15, Volume: 35, Issue:8

    Topics: Acyclovir; Antiviral Agents; Chemoprevention; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Organophosphonates; Organophosphorus Compounds; Postoperative Complications; Risk Factors; Transplantation, Autologous; Transplantation, Homologous; Valacyclovir; Valganciclovir; Valine

2002
High dosage of oral valaciclovir as an alternative treatment of varicella zoster acute retinal necrosis syndrome.
    Eye (London, England), 2006, Volume: 20, Issue:2

    Topics: Acyclovir; Antiviral Agents; Eye Infections, Viral; Ganciclovir; Herpes Zoster; Humans; Retinal Necrosis Syndrome, Acute; Valacyclovir; Valganciclovir; Valine

2006
Reactivity of valganciclovir in aqueous solution.
    Drug development and industrial pharmacy, 2005, Volume: 31, Issue:9

    Topics: Buffers; Chromatography, High Pressure Liquid; Ganciclovir; Half-Life; Hydrogen-Ion Concentration; Hydrolysis; Kinetics; Solutions; Stereoisomerism; Valganciclovir; Valine

2005
Anti-cytomegalovirus prophylaxis in solid-organ transplant recipients.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2006, Volume: 12, Issue:7

    Topics: Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Ganciclovir; Humans; Organ Transplantation; Valacyclovir; Valganciclovir; Valine

2006
Molecular basis of prodrug activation by human valacyclovirase, an alpha-amino acid ester hydrolase.
    The Journal of biological chemistry, 2008, Apr-04, Volume: 283, Issue:14

    Topics: Acyclovir; Animals; Antiviral Agents; Binding Sites; Carboxylic Ester Hydrolases; Crystallography, X-Ray; Ganciclovir; Humans; Hydrophobic and Hydrophilic Interactions; Mutation; Phylogeny; Prodrugs; Protein Structure, Tertiary; Valacyclovir; Valganciclovir; Valine

2008
Valganciclovir versus valaciclovir for prevention of alemtuzumab-induced cytomegalovirus reactivation: what are the implications for routine clinical practice?
    Blood, 2008, Sep-01, Volume: 112, Issue:5

    Topics: Acyclovir; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Antiviral Agents; Cytomegalovirus Infections; Ganciclovir; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Valacyclovir; Valganciclovir; Valine

2008
L-valine ester of cyclopropavir: a new antiviral prodrug.
    Antiviral chemistry & chemotherapy, 2009, Sep-25, Volume: 20, Issue:1

    Topics: Animals; Antiviral Agents; Biological Availability; Cyclopropanes; Cytomegalovirus; Esters; Ganciclovir; Guanine; Humans; Hydrolysis; Mice; Prodrugs; Valganciclovir; Valine; Virus Replication

2009
Six months anti-viral prophylaxis significantly decreased cytomegalovirus disease compared with no anti-viral prophylaxis following renal transplantation.
    Transplant international : official journal of the European Society for Organ Transplantation, 2010, Volume: 23, Issue:9

    Topics: Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Female; Follow-Up Studies; Ganciclovir; Graft Survival; Humans; Incidence; Injections, Intravenous; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Prodrugs; Retrospective Studies; Survival Rate; Time Factors; Treatment Outcome; Valacyclovir; Valganciclovir; Valine

2010
Neutropenia related to valacyclovir and valganciclovir in 2 renal transplant patients and treatment with granulocyte colony stimulating factor: a case report.
    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2010, Volume: 8, Issue:2

    Topics: Acyclovir; Adolescent; Adult; Antiviral Agents; Cytomegalovirus Infections; Filgrastim; Ganciclovir; Granulocyte Colony-Stimulating Factor; Humans; Kidney Transplantation; Male; Neutropenia; Recombinant Proteins; Treatment Outcome; Valacyclovir; Valganciclovir; Valine

2010
Atypical presentation of cytomegalovirus endotheliitis: a case report.
    Ocular immunology and inflammation, 2011, Volume: 19, Issue:1

    Topics: Acyclovir; Aged; Antiviral Agents; Corneal Edema; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Endothelium, Corneal; Ganciclovir; Humans; Intraocular Pressure; Keratitis, Herpetic; Male; Prednisolone; Valacyclovir; Valganciclovir; Valine; Visual Acuity

2011
Valganciclovir prophylaxis against cytomegalovirus impairs lymphocyte proliferation and activation in renal transplant recipients.
    Antiviral therapy, 2011, Volume: 16, Issue:8

    Topics: Acyclovir; Adult; Antiviral Agents; Cell Proliferation; Cells, Cultured; Concanavalin A; Cytomegalovirus; Cytomegalovirus Infections; Female; Ganciclovir; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Lymphocyte Activation; Lymphocyte Count; Male; Middle Aged; Phytohemagglutinins; T-Lymphocyte Subsets; Valacyclovir; Valganciclovir; Valine

2011
Randomized trial of pre-emptive or prophylactic valganciclovir therapy for prevention of cytomegalovirus infection in renal transplantation.
    Journal of the American Society of Nephrology : JASN, 2012, Volume: 23, Issue:9

    Topics: Acyclovir; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Female; Ganciclovir; Humans; Kidney Transplantation; Male; Valacyclovir; Valganciclovir; Valine

2012
Cytomegalovirus prophylaxis in solid organ transplantation.
    Current medicinal chemistry, 2012, Volume: 19, Issue:35

    Topics: Acyclovir; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Ganciclovir; Graft Rejection; Humans; Immunity, Cellular; Immunosuppressive Agents; Risk Factors; Tissue Transplantation; Valacyclovir; Valganciclovir; Valine

2012
Cytomegalovirus prophylaxis in pediatric kidney transplantation: the Dutch experience.
    Pediatric transplantation, 2013, Volume: 17, Issue:6

    Topics: Acyclovir; Adolescent; Antiviral Agents; Child; Child, Preschool; Cytomegalovirus; Cytomegalovirus Infections; Disease-Free Survival; Ganciclovir; Humans; Immunoglobulins; Immunosuppressive Agents; Infant; Kidney Transplantation; Netherlands; Polymerase Chain Reaction; Receptors, Interleukin-2; Renal Insufficiency; Retrospective Studies; Risk; Valacyclovir; Valganciclovir; Valine

2013
Valganciclovir versus valacyclovir prophylaxis for prevention of cytomegalovirus: an economic perspective.
    Transplant infectious disease : an official journal of the Transplantation Society, 2015, Volume: 17, Issue:3

    Topics: Acyclovir; Adult; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Female; Follow-Up Studies; Ganciclovir; Humans; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Valacyclovir; Valganciclovir; Valine

2015